SEATTLE, April 27, 2016 /PRNewswire/ — LumiThera ® Inc., a late-stage developmental medical device company creating a non-invasive photobiomodulation (PBM) treatment for ocular disorders and disease, today announced it has been awarded the prestigious “MOST PROMISING AND INNOVATIVE CATALYZER AWARD” during Biovision 2016, Lyon, France. Biovision is a high-level investor event connecting industrial partners, financial… Continue reading

Posted on April 28th, 2016 in Press Releases | Comments Off on LumiThera Named Most Promising and Innovative Catalyzer Startup at BIOVISION 2016

SEATTLE, March 24, 2016 /PRNewswire/ — LumiThera Inc., a developmental stage medical device company creating a non-invasive photobiomodulation (PBM) treatment for ocular disorders and disease, today announced it has obtained Health Canada approval of their LIGHTSITE clinical study to treat dry Age-related Macular Degeneration (AMD) subjects. The pilot clinical trial is in part sponsored by… Continue reading

Posted on March 24th, 2016 in Press Releases | Comments Off on LumiThera Obtains Approval by Health Canada to Start Age-related Macular Degeneration Clinical Study

SEATTLE, Sept. 29, 2015 /PRNewswire/ — LumiThera Inc., a developmental stage medical device company creating a non-invasive photobiomodulation (PBM) treatment for ocular disorders and disease, today announced it is a recipient of a two small business innovative research (SBIR) phase I grants from the National Institute of Health (NIH) and the division of the National… Continue reading

Posted on September 30th, 2015 in Press Releases | Comments Off on LumiThera Receives Notice of Awards for two National Eye Institute Grants

SEATTLE, May 27, 2015 /PRNewswire/ — LumiThera Inc., a developmental stage medical device company creating a non-invasive photobiomodulation (PBM) treatment for ocular disorders and disease, announced today that they were awarded a Washington State Life Sciences Discovery Fund (LSDF) commercialization grant. LumiThera was 1 of 3 recipients of the LSDF matching grants worth $500,000 to… Continue reading

Posted on May 28th, 2015 in Press Releases | Comments Off on LumiThera Receives LSDF Commercialization Grant Award

Clark E. Tedford,¹ Scott DeLapp,¹ Steven Jacques,² and Juanita Anders³ ¹LumiThera, Inc., Poulsbo, Washington 98370 ²Oregon Health and Science University, Portland, Oregon ³Department of Anatomy, Physiology and Genetics, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814 Background and Objective: Photobiomodulation (PBM) also known as low-level light therapy has been used successfully for the… Continue reading

Posted on May 7th, 2015 in Research Articles | Comments Off on Quantitative Analysis of Transcranial and Intraparenchymal Light Penetration in Human Cadaver Brain Tissue

SEATTLE, May 6, 2015 /PRNewswire/ — LumiThera Inc., a medical device company focused on the development of non-invasive photobiomodulation (PBM) treatment for ocular disorders and disease, today announced Retired Congressman Norman Dicks has agreed to join LumiThera’s Advisory Board to assist in the company’s mission to treat vision impairment. Norman DeValois “Norm” Dicks was the… Continue reading

Posted on May 6th, 2015 in Press Releases | Comments Off on Retired Congressman Norman Dicks Joins LumiThera’s Advisory Team

Passarella S, Karu T. Institute of Laser and Information Technologies of the Russian Academy of Sciences, 142190 Troitsk, Moscow Region, Russian Federation. Abstract In addition to the major functions performed by in the cell, mitochondria play a major role in cell-light interaction. Accordingly it is generally accepted that mitochondria are crucial in cell photobiomodulation; however… Continue reading

Posted on October 1st, 2014 in Research Articles | Comments Off on Absorption of Monochromatic and Narrow Band Radiation in the Visible and Near IR by Both Mitochondrial and Non-Mitochondrial Photoacceptors Results in Photobiomodulation

SEATTLE, June 9, 2014 /PRNewswire/ – LumiThera Inc., a medical device company focused on the development of non-invasive light emitting diode (LED) treatments for ocular disorders and disease, today announced Ret. Major General Gale Pollock has joined their Scientific Advisory Board. The first woman to serve as Acting Surgeon General of the United States Army… Continue reading

Posted on June 10th, 2014 in Press Releases | Comments Off on Retired Major General Gale Pollock Joins LumiThera’s Scientific Advisory Board

United Nations Headquarters (New York) presentation to the Global Health Impact Forum, 6th May 2014 by co founder James Carroll This 15 minute video starts with an overview of Photobiomodulation and low level light therapy as it relates to his company THOR Photomedicine. Later in the presentation James introduces Lumithera and our treatment for Age related… Continue reading

Posted on May 12th, 2014 in Press Releases | Comments Off on Video Introduction

Begum R, Powner MB, Hudson N, Hogg C, Jeffery G Institute of Ophthalmology, University College London, London, United Kingdom. Abstract Inflammation is an umbrella feature of ageing. It is present in the aged retina and many retinal diseases including age-related macular degeneration (AMD). In ageing and in AMD mitochondrial function declines. In normal ageing this… Continue reading

Posted on April 30th, 2014 in Research Articles | Comments Off on Treatment with 670 nm Light Upregulates Cytochrome C Oxidase Expression and Reduces Inflammation in an Age-Related Macular Degeneration Model